✦ LIBER ✦

Haemophagocytic syndrome and paradoxical reaction to tuberculostatics after treatment with infliximab

✍ Scribed by Mariño, Amelia Troncoso ;Sánchez, Eva Campelo ;Castro, Noemí Martínez López ;Bobo, María Teresa Inaraja

Book ID: 106494868
Publisher: Springer
Year: 2010
Tongue: Dutch
Weight: 128 KB
Volume: 32
Category: Article
ISSN: 1573-739X
DOI: 10.1007/s11096-010-9369-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favourable outcome of life-threatening i

Favourable outcome of life-threatening infectious-related haemophagocytic syndrome after combination treatment with corticosteroids and intravenous immunoglobulin infusions

✍ Catherine K. Argyraki; Stella Gabeta; Kalliopi Zachou; Maria Boulbou; Asterios P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Delayed hypersensitivity reaction with i

Delayed hypersensitivity reaction with infliximab: Unusual to occur after initial dose

✍ Mazer R. Ally; John D. Betteridge; Ganesh R. Veerappan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Effect of antibodies to infliximab on in

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing Crohn's disease receiving maintenance treatment with infliximab

✍ Wagner, Carrie; Ford, Joyce; Marsters, Paul; Travers, Suzanne; Bao, Weihang; Dev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Successful treatment with nab-paclitaxel

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

✍ de Leon, Maria C.B.; Bolla, Sridhar; Greene, Barbra; Hutchinson, Lauren; Del Pri 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 140 KB

Failure of hepatopulmonary syndrome to r

Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy

✍ John J. Poterucha; Michael J. Krowka; E. Rolland Dickson; Denis A. Cortese; Anth 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views